The Swedish BioFINDER 2 Study

NCT03174938 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

2950

Enrollment

OTHER

Sponsor class

Conditions

Dementia
Alzheimer Disease
Parkinson Disease
Lewy Body Disease
Parkinson-Dementia Syndrome
Frontotemporal Degeneration
Semantic Dementia
Progressive Nonfluent Aphasia
Progressive Supranuclear Palsy
Corticobasal Degeneration
Multiple System Atrophy
Mild Cognitive Impairment
ALS (Amyotrophic Lateral Sclerosis)

Interventions

DIAGNOSTIC_TEST: Flutemetamol F18 Injection
DIAGNOSTIC_TEST: [18F]-RO6958948
DIAGNOSTIC_TEST: Elecsys (Roche) Abeta42, Ttau and Ptau
DIAGNOSTIC_TEST: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau

Sponsor

Skane University Hospital

Collaborators

[object Object]